Last updated 2026-07-20
- Acquired by Venus Medtech for $300M, Dec 2021
- Raised $40M Undisclosed Round led by Amir Gross, Jul 2020
- Raised $5.5M Undisclosed Round led by Peregrine Ventures, Oct 2016
Total raised
$45.5M
Last: Undisclosed Round 2020-08
Stage
Acquired
Founded
2010
Headcount
125
HQ
Or Yehuda, Israel
Sector
Health Tech & Life Sciences
About
Cardiovalve developed a transcatheter valve replacement system designed to treat both mitral and tricuspid anatomies. The system is delivered transfemorally, avoiding the need for open-heart surgery, and offers benefits such as a short profile to minimize ventricular protrusion, a robust anchoring mechanism, and an enhanced sealing solution to prevent paravalvular leaks. Cardiovalve was originally a spin-off of Valtech Cardio, which was acquired by Edwards Lifesciences in 2017.
Funding history · 2 rounds · $45.5M total
2020-07
Undisclosed Round
$40.0M
★ Amir Gross★ NGN Capital★ OXO Ventures★ GlenRock Group★ Peregrine Ventures★ Edwards Lifesciences
2016-10
Undisclosed Round
$5.5M
★ Peregrine Ventures
Headcount over time
From 49 (2022-10) to 40 (2026-07) · -9 (-18%) · 16 points · source: Finder history + radar grounding
Q&A
- What is Cardiovalve's primary focus?
- Cardiovalve develops cardiovascular replacement devices for minimally invasive surgery, specifically focusing on a transfemoral system to replace the mitral valve.
- When was Cardiovalve acquired and by whom?
- Cardiovalve was acquired by Venus Medtech in March 2022.
- What is the status of Cardiovalve's FDA approvals?
- Cardiovalve received FDA approval for an Early Feasibility Study of its Transcatheter Tricuspid Valve Replacement System and has been granted Breakthrough Device Designation status by the FDA.
- What was Cardiovalve's total funding raised before its acquisition?
- Cardiovalve raised a total of $45,483,000.
- Who were the investors in Cardiovalve's August 2020 funding round?
- In August 2020, Cardiovalve received funding from investors including Edwards Lifesciences.
- What is Cardiovalve's employee count?
- Cardiovalve has 51–200 employees.
- Who is the CEO of Cardiovalve?
- Amir Gross is the CEO of Cardiovalve and also a founder.
- What is Cardiovalve's connection to Valtech Cardio?
- Cardiovalve is a spin-off of Valtech Cardio, which was acquired by Edwards Lifesciences in 2017.
Team · 1
Amir Gross
Founder · CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B
Highlights
1 Patents
Tags
doctorscatheterssurgeryvalveshospitalsmedical-devicescardiologyheart-diseasesminimally-invasive
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | cardiovalve.com |
|---|---|
| linkedin.com/company/33191238 |
Identifiers & details
| Legal name | Cardiovalve Ltd. |
|---|---|
| Former names | MITRALTECH |
| Founded | 2010 |
| Employees (exact) | 125 |
| Status reason | Acquired by Venus Medtech on Mar, 2022 |
Acquisitions & public offerings
Acquired by Venus Medtech 2021-12 $300.0M
Radar intelligence
Patents
| EPO | 40 |
|---|
Web history (Wayback)
| Domain | cardiovalve.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514381060 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2010-01-07 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 1 |
| Registry events | 3 — annual_report (2), charge (1) |
| Registered address | יהדות קנדה 1 אור יהודה |
Recent registry events
| Date | Event |
|---|---|
| 2026-04-28 | דו~ח שנתי-הוספת דירקטור |
| 2026-04-28 | דו~ח שנתי-הסרת דירקטור |
| 2025-11-25 | רישום שעבוד |